Menu
MapConnectionsTopicsBulgariaThe Night (K-TRIO)Marie Skłodowska-CurieFor studentsFor teachersMethodologySurprise me
H2020Doctoral network2017–2022

TRAIN-EV · Training in Extracellular Vesicles: for benefit in Health and Disease

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2017-10-01 → 2022-03-31
EU contribution
€3,724,252
Participants
10
Scheme
MSCA-ITN

Lines connect the coordinator with its partners.

Results in brief

Training in Extracellular Vesicles: for benefit in Health and Disease

In the Reporting Period of TRAIN-EV (01/10/2019-31/03/2022) all ESRs either completed their projects or progressed onto another funding stream identified by their supervisors in order for them to complete and submit their PhDs. The 17 remaining Deliverables were submitted, and the 6 remaining Milestones achieved. Dissemination, by the ESRs was in the form of 29 oral presentations at conferences, 26 posters presentation at meetings, and 28 peer-reviewed publications. TRAIN-EV research was further highlighted and the H2020 funding gratefully received was acknowledged in 32 talks/keynotes, 10 peer-reviewed publications, and 9 exhibitions by Coordinators, Beneficiaries or Partner Organisations. We are very grateful to our Project Officer, Domna Paschalidou, for her advice, guidance, and support during this time, which was made challenging due to covid-19. However, our overall lasting impression of TRAIN-EV has been a time of great scientific collaboration and progress.

Data: CORDIS, © European Union

Project objective

Exosomes and microvesicles/ectosomes, collectively termed extracellular vesicles (EV), have attracted much recent interest because of their potential functions, use as disease biomarkers and possible therapeutic exploitation. Due to their enormous relevance, this relatively new field of research is quickly expanding. While Europe leads the field of EV research, there are still many gaps in knowledge that need to be addressed to ensure optimal exploitation of EVs from health and Europe’s economic benefit. Addressing this, TRAIN-EV’s objective is to provide excellent and integrated multi-disciplinary and inter-sectoral training of a critical mass of ESRs of outstanding potential in the academic, clinical, and industry/business components of exploiting EV, while performing novel cutting-edge research to address these gaps and generate new knowledge. This will be achieved by appointing 15 ESRs into 10 Beneficiary Organisations (6 academic; 4 non-academic), with 4 additional Partner Organisations (3 non-academic; 1 academic) offering secondments, training and additional networking opportunities. All Participants have highly relevant and complementary medical/science/engineering/business expertise –detailed within– that will collectively contribute to the training, to PhD level, of these 15 ESRs as academic and industry EV leaders for the future.

Original text from CORDIS.

Participants

  • THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN · DublinCoordinatorIreland
  • AJ INNUSCREEN GMBH · BerlinGermany
  • BIOINF2BIO LDA · PortoPortugal
  • GVS SPA · Zola PredosaItaly
  • HANSABIOMED LIFE SCIENCES OU · TALLINNEstonia
  • INSTITUT CURIE · ParisFrance
  • SEMMELWEIS EGYETEM · BudapestHungary
  • UNIVERSITAETSKLINIKUM FREIBURG · FreiburgGermany
  • UNIVERSITEIT GENT · GentBelgium
  • UNIVERSITEIT UTRECHT · UtrechtNetherlands

Links

Data: CORDIS, © European Union